Gene therapy for bone healing: lessons learned and new approaches.

Translational Research : the Journal of Laboratory and Clinical Medicine
Rodolfo E De la VegaElizabeth R Balmayor

Abstract

Although gene therapy has its conceptual origins in the treatment of Mendelian disorders, it has potential applications in regenerative medicine, including bone healing. Research into the use of gene therapy for bone healing began in the 1990s. Prior to this period, the highly osteogenic proteins bone morphogenetic protein (BMP)-2 and -7 were cloned, produced in their recombinant forms and approved for clinical use. Despite their promising osteogenic properties, the clinical usefulness of recombinant BMPs is hindered by delivery problems that necessitate their application in vastly supraphysiological amounts. This generates adverse side effects, some of them severe, and raises costs; moreover, the clinical efficacy of the recombinant proteins is modest. Gene delivery offers a potential strategy for overcoming these limitations. Our research has focused on delivering a cDNA encoding human BMP-2, because the recombinant protein is Food and Drug Administration approved and there is a large body of data on its effects in people with broken bones. However, there is also a sizeable literature describing experimental results obtained with other transgenes that may directly or indirectly promote bone formation. Data from experiments in...Continue Reading

References

Oct 1, 1992·Nature Genetics·T Friedmann
Apr 1, 1992·DNA and Cell Biology·G BandaraC H Evans
Mar 3, 1972·Science·T Friedmann, R Roblin
Jul 1, 1995·The Journal of Bone and Joint Surgery. American Volume·C H Evans, P D Robbins
Jul 22, 1998·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J R LiebermanS Stevenson
Jan 26, 1999·Clinical Orthopaedics and Related Research·C NiyibiziC H Evans
May 13, 1999·Lancet·A Van Heest, M Swiontkowski
Jul 13, 1999·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·A W BaltzerC H Evans
Sep 3, 1999·The Orthopedic Clinics of North America·A A Scaduto, J R Lieberman
Feb 24, 2001·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·P Bosch Huard
Jun 12, 2003·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Jason L DragooProsper Benhaim
Aug 20, 2004·Plastic and Reconstructive Surgery·Oliver O AalamiMichael T Longaker
Dec 4, 2004·Clinical Orthopaedics and Related Research·Christopher H EvansPaul D Robbins
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Christopher H EvansJames H Herndon
Feb 3, 2006·The Journal of Bone and Joint Surgery. American Volume·Oliver B BetzChristopher H Evans
Apr 28, 2006·Gene Therapy·M EgermannA W Baltzer
Jun 22, 2006·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Brian T FeeleyJay R Lieberman
Sep 5, 2006·The Journal of Bone and Joint Surgery. American Volume·Ph HernigouH Rouard
May 24, 2007·Tissue Engineering·Chris H EvansSteven C Ghivizzani
Jul 26, 2008·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Ryan M PorterChristopher H Evans
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Jan 15, 2010·European Cells & Materials·C H EvansM S Vrahas
Jun 18, 2010·The Cochrane Database of Systematic Reviews·Kimberly R GarrisonVolker Alt
Jun 24, 2010·Expert Reviews in Molecular Medicine·Christopher H Evans
Feb 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mandeep S VirkJay R Lieberman
Jan 4, 2012·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Fangjun LiuChristopher H Evans
Apr 7, 2012·Advanced Drug Delivery Reviews·C H Evans
Jun 26, 2012·Advanced Drug Delivery Reviews·Elliott GruskinJeffrey O Hollinger
Jan 22, 2014·Human Gene Therapy·Ronald G Crystal
Feb 21, 2014·The Journal of Bone and Joint Surgery. American Volume·M P A BusJ A M Bramer
Jun 15, 2014·The Spine Journal : Official Journal of the North American Spine Society·Branko SkovrljSheeraz A Qureshi
Feb 24, 2015·Frontiers in Bioengineering and Biotechnology·Elizabeth Rosado Balmayor, Martijn van Griensven
Mar 19, 2015·Journal of Tissue Engineering and Regenerative Medicine·Christian W MüllerElizabeth Rosado Balmayor
Feb 10, 2016·Tissue Engineering. Part B, Reviews·Aaron W JamesChia Soo
Mar 5, 2016·Oncoimmunology·Jonathan PolLorenzo Galluzzi
May 22, 2016·Injury·C H Evans, M J Stoddart
Sep 8, 2016·JAMA Surgery·Robert ZuraR Grant Steen
Sep 23, 2016·The AAPS Journal·Sheetal D'MelloAliasger K Salem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.